Hepatobiliary Surgery Practice Questions

Q: A 70-year-old male presented with progressive jaundice for 6 weeks, fever, pruritis along with abdominal pain and significant weight loss. Lab findings reveal total serum bilirubin of 22 mg/dL, minimally elevated SGOT/SGPT, and increased alkaline phosphatase. A CT abdomen and ERCP were performed. What is the most common site of this pathology?

Hilum. ***Hilum*** - The **hilum** is the most common site of **cholangiocarcinoma** (~60-70%), known as **Klatskin tumor**, presenting with the classic **obstructive jaundice pattern** seen in this case. - **Hilar tumors** cause early biliary obstruction leading to **high alkaline phosphatase**, **high bilirubin**, and **minimal transaminase elevation**, classified by **Bismuth-Corlette system**. *Intrahepatic bile duct* - **Intrahepatic cholangiocarcinoma** represents only ~20-25% of all cholangiocarcinomas, making it less common than hilar tumors. - These tumors typically present as **mass lesions** rather than causing early **obstructive jaundice** with such pronounced biochemical changes. *Distal common bile duct* - **Distal cholangiocarcinoma** accounts for ~20-30% of cases and would cause similar **obstructive pattern** but is less common than hilar location. - These tumors are often **resectable** unlike hilar tumors, and may present with **palpable gallbladder** (**Courvoisier's sign**). *Proximal common bile duct* - **Proximal common bile duct** tumors are relatively uncommon compared to **hilar cholangiocarcinoma**. - The anatomical distinction between proximal CBD and hilar tumors is often unclear, with **hilar involvement** being the predominant pattern in this region.

Q: A 50-year-old man presents with a one-week history of fever and abdominal pain. An abdominal ultrasound revealed a hypoechoic liver lesion, and a CECT was performed for characterization. Which of the following statements regarding the lesion is false?

Hematogenous spread is the most common source of infection.. ### Explanation The clinical presentation of fever, abdominal pain, and a hypoechoic liver lesion on imaging in an older male is highly suggestive of a **Pyogenic Liver Abscess (PLA)**. **Why Option C is the correct (False) statement:** Historically, portal vein spread (from appendicitis or diverticulitis) was the most common route. However, in modern practice, **biliary tract disease** (e.g., gallstones, strictures, or malignancy causing ascending cholangitis) has become the **most common source** of infection, accounting for 40–60% of cases. Hematogenous spread via the hepatic artery (usually from endocarditis or dental infections) is less common. **Analysis of other options:** * **Option A (True):** *E. coli* remains the most common aerobic organism isolated globally. However, *Klebsiella pneumoniae* is increasingly common, especially in diabetic patients and in Southeast Asian populations. * **Option B (True):** The **right lobe** is the most common site (involved in ~75% of cases). This is attributed to its larger size and the "streaming effect" of portal blood flow, which preferentially directs flow from the superior mesenteric vein to the right lobe. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Investigation:** Triple-phase CECT (shows a peripheral enhancing rim with a central non-enhancing necrotic area—the "cluster sign"). * **Most common symptom:** Fever (more common than jaundice or palpable mass). * **Management:** The mainstay of treatment is **percutaneous needle aspiration or catheter drainage** combined with long-term intravenous antibiotics. Surgical drainage is reserved for ruptured abscesses or failed percutaneous attempts. * **Amoebic vs. Pyogenic:** Amoebic abscesses are usually solitary, located in the subdiaphragmatic area of the right lobe, and present with "anchovy sauce" pus.

Q: Okuda staging for HCC includes all except?

Prothrombin time. The **Okuda Staging System** is a prognostic classification for Hepatocellular Carcinoma (HCC) that combines elements of liver function with tumor characteristics. It is particularly useful in advanced cases to predict survival. ### **Explanation of the Correct Answer** **Option C (Prothrombin Time)** is the correct answer because it is **not** a component of the Okuda system. While Prothrombin Time (PT/INR) is a vital part of the Child-Pugh score (used to assess liver cirrhosis), the Okuda system utilizes **Serum Bilirubin** instead to assess the excretory function of the liver. ### **Analysis of Incorrect Options** The Okuda system uses four specific parameters, each scored as positive or negative based on a threshold: * **A. Ascites:** Included as a clinical marker of portal hypertension and liver failure (Positive if clinically detectable). * **B. Albumin:** Included as a marker of the liver's synthetic function (Positive if 50% of the liver area). * *(Note: The fourth parameter not listed in the options is **Serum Bilirubin**, positive if >3 mg/dL).* ### **Clinical Pearls for NEET-PG** * **Okuda Scoring:** * Stage I (Not advanced): 0 points. * Stage II (Moderately advanced): 1–2 points. * Stage III (Very advanced): 3–4 points. * **Comparison:** Unlike the **BCLC (Barcelona Clinic Liver Cancer)** staging, which is the current gold standard for treatment algorithms, the Okuda system is older and primarily focuses on prognosis in advanced disease. * **High-Yield Fact:** If a question asks for the staging system that includes **Portal Vein Invasion** or **Performance Status**, think of **BCLC** or **CLIP (Cancer of the Liver Italian Program)** scores.

Q: Which of the following is a criterion for assessing the prognosis of a portosystemic shunt?

Type of shunt. **Explanation:** The prognosis and outcome of a portosystemic shunt are primarily determined by the **type of shunt** performed. Shunts are classified into three categories: **Total** (e.g., end-to-side portacaval), **Partial** (e.g., small-diameter prosthetic H-graft), and **Selective** (e.g., Distal Splenorenal/Warren shunt). The underlying medical concept is the preservation of **portal perfusion**. Total shunts divert all portal blood away from the liver, leading to a high incidence of hepatic encephalopathy and accelerated liver failure. Selective shunts, however, decompress varices while maintaining mesenteric blood flow to the liver, resulting in significantly better long-term metabolic prognosis and quality of life. **Analysis of Incorrect Options:** * **Serum Albumin & Serum Bilirubin (Options A & C):** These are components of the **Child-Pugh Score**, which assesses the *severity of underlying liver disease* and surgical risk (operability), rather than the specific prognosis of the shunt procedure itself. * **Resistant Ascites (Option B):** This is an *indication* for a shunt (specifically a Side-to-Side portacaval shunt or TIPS) rather than a prognostic criterion for the shunt’s success. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Selective Shunt:** Distal Splenorenal Shunt (Warren Shunt). * **Best Shunt for Ascites:** Side-to-Side Portacaval Shunt (it decompress the hepatic sinusoids). * **Most Common Cause of Shunt Failure:** Thrombosis of the shunt. * **TIPS (Transjugular Intrahepatic Portosystemic Shunt):** Acts as a side-to-side shunt; the main complication is stenosis/occlusion.

Q: What is the ideal treatment for stenosis of the sphincter of Oddi?

Endoscopic sphincterotomy. **Explanation:** The treatment of choice for **Sphincter of Oddi Dysfunction (SOD)**, specifically Type I (stenosis) and Type II (functional), has shifted from invasive surgery to minimally invasive endoscopic techniques. **Why Endoscopic Sphincterotomy is Correct:** Endoscopic Retrograde Cholangiopancreatography (ERCP) with **Endoscopic Sphincterotomy (EST)** is the gold standard treatment. It involves an electrosurgical incision of the biliary and/or pancreatic sphincter. It is preferred because it is less invasive than open surgery, has a high success rate in relieving biliary pain and improving laboratory values, and carries a lower morbidity rate compared to transduodenal approaches. **Analysis of Incorrect Options:** * **A. Transduodenal Sphincteroplasty:** This was historically the treatment of choice. While effective, it requires a formal laparotomy and duodenotomy, leading to longer recovery times and higher surgical risks. It is now reserved for cases where ERCP fails or is technically impossible (e.g., altered anatomy). * **C & D. Choledochojejunostomy / Choledochoduodenostomy:** These are biliary bypass (drainage) procedures. They are indicated for distal common bile duct (CBD) strictures, chronic pancreatitis, or "sump syndrome," but they are considered "overkill" for isolated sphincter stenosis and do not address the primary pathology at the sphincter itself. **NEET-PG High-Yield Pearls:** * **Milwaukee Classification:** SOD is classified into three types. Type I (Stenosis) shows dilated CBD (>10mm) and delayed contrast drainage (>45 mins); it responds best to EST. * **Manometry:** Sphincter of Oddi Manometry (SOOM) is the "Gold Standard" for diagnosis, specifically for Type II. A basal pressure **>40 mmHg** is diagnostic. * **Risk:** Post-ERCP pancreatitis is the most common complication of EST; prophylactic pancreatic stents are often used to mitigate this risk.

Q: All of the following modalities can be used for in situ ablation of liver secondaries, except?

Ultrasonic waves. **Explanation:** The goal of in situ ablation is to destroy tumor tissue (liver secondaries) directly within the organ using thermal, chemical, or electrical energy. **Why Ultrasonic Waves is the Correct Answer:** Diagnostic **ultrasonic waves** (Ultrasound) are used for **imaging and guidance** during ablation procedures, but they do not possess the energy density required to destroy tissue in situ. While a specific technology called HIFU (High-Intensity Focused Ultrasound) exists, standard ultrasonic waves are non-invasive imaging tools, not an ablative modality themselves. Therefore, it is the "except" in this list. **Analysis of Other Options:** * **Alcohol (Chemical Ablation):** Percutaneous Ethanol Injection (PEI) involves injecting absolute alcohol into the lesion, causing immediate protein denaturation and cellular dehydration, leading to coagulative necrosis. It is highly effective for small hepatocellular carcinomas and some secondaries. * **Radiofrequency Ablation (RFA):** This is the most common thermal ablation technique. It uses high-frequency alternating current to generate frictional heat (60°C–100°C), causing thermal coagulation and tissue death. * **Cryotherapy (Cryoablation):** This involves the use of a cryoprobe (using liquid nitrogen or argon gas) to freeze the tumor tissue to temperatures as low as -40°C. The formation of intracellular ice crystals leads to cell membrane disruption and vascular stasis. **Clinical Pearls for NEET-PG:** * **Gold Standard for Small HCC:** RFA is generally preferred over PEI for lesions >2 cm due to better local control. * **Microwave Ablation (MWA):** A newer thermal modality that is faster than RFA and less affected by the "heat-sink effect" (cooling by adjacent large blood vessels). * **Indication:** Ablation is typically indicated for patients with limited liver secondaries (usually <3-5 lesions, <3 cm each) who are not candidates for surgical resection.

Q: What is the most common cause of isolated gastric varices?

Splenic vein thrombosis. **Explanation:** The presence of **isolated gastric varices (IGV)** in the absence of esophageal varices is a classic clinical hallmark of **left-sided (sinistral) portal hypertension**. **1. Why Splenic Vein Thrombosis (SVT) is correct:** The splenic vein drains the spleen and receives blood from the short gastric veins. When the splenic vein is obstructed (most commonly due to **chronic pancreatitis**, pancreatic pseudocysts, or pancreatic tumors), blood is diverted through the **short gastric veins** into the submucosal veins of the gastric fundus to reach the portal system. This increased pressure leads to the formation of isolated gastric varices. Unlike generalized portal hypertension (cirrhosis), the pressure in the rest of the portal system remains normal, which is why esophageal varices are typically absent. **2. Analysis of Incorrect Options:** * **Option A (Profuse bleeding):** While gastric varices can bleed more severely than esophageal varices, "profuse bleeding" is a clinical presentation/complication, not a cause. * **Option C (EUS vs. Endoscopy):** This is a diagnostic comparison. While EUS is highly sensitive for detecting underlying vessels, it is not a "cause" of the condition. * **Option D (Single treatment):** This is a statement regarding management (often involving cyanoacrylate glue or splenectomy). It does not address the etiology. **High-Yield Pearls for NEET-PG:** * **Most common cause of SVT:** Chronic Pancreatitis. * **Definitive Treatment:** Splenectomy is curative for IGV caused by SVT. * **Classification:** Gastric varices are classified by the **Sarin Classification** (IGV Type 1 are located in the fundus). * **Medical Management:** Endoscopic injection of **N-butyl-2-cyanoacrylate** (glue) is the preferred endoscopic intervention for bleeding gastric varices.

Q: Which of the following statements is not true regarding Milan's criteria?

Fewer than 5 nodules. **Explanation:** The **Milan Criteria** are the gold standard guidelines used to determine the eligibility of patients with Hepatocellular Carcinoma (HCC) for **Orthotopic Liver Transplantation (OLT)**. These criteria were established to select patients who would achieve post-transplant survival rates comparable to those transplanted for non-malignant conditions. **Why Option C is the correct answer (Not True):** The Milan Criteria do not allow for "fewer than 5 nodules." The criteria strictly limit the number of tumors to a **maximum of three** if they are small. Any patient with four or more nodules falls outside the Milan Criteria, regardless of the size of the nodules. **Analysis of Incorrect Options (True Statements):** * **Option A (Single tumor <5 cm):** This is the primary criterion for solitary lesions. A single HCC up to 5 cm in diameter is considered within the "Milan-in" zone. * **Option B (Up to 3 nodules, each <3 cm):** For multifocal disease, the criteria allow for a maximum of 3 nodules, provided none exceed 3 cm in diameter. * **Option D (No extrahepatic spread):** This is a mandatory requirement. The presence of extrahepatic metastasis or **macrovascular invasion** (e.g., portal vein thrombosis) is an absolute contraindication for transplantation under these criteria. **High-Yield Clinical Pearls for NEET-PG:** * **UCSF Criteria:** An expansion of Milan, allowing a single lesion up to 6.5 cm or 2–3 lesions up to 4.5 cm (total diameter ≤8 cm). * **Bridging Therapy:** While waiting for a transplant, patients within Milan criteria often undergo TACE or RFA to prevent "dropout" due to tumor progression. * **Survival:** Patients meeting Milan criteria have a 5-year survival rate exceeding 70% post-transplant.

Question 1

A patient with compensated liver cirrhosis presented with a history of variceal bleed. What is the preferred mode of treatment in this patient?

Accepted Answer

Endoscopic sclerotherapy

Answer

Propranolol

Answer

Liver transplantation

Answer

TIPS

Question 2

A 70-year-old male presented with progressive jaundice for 6 weeks, fever, pruritis along with abdominal pain and significant weight loss. Lab findings reveal total serum bilirubin of 22 mg/dL, minimally elevated SGOT/SGPT, and increased alkaline phosphatase. A CT abdomen and ERCP were performed. What is the most common site of this pathology?

Accepted Answer

Hilum

Answer

Intrahepatic bile duct

Answer

Distal common bile duct

Answer

Proximal common bile duct

Question 3

Which of the following are included in the Child criteria?

Accepted Answer

Serum bilirubin and serum creatinine

Answer

Nutritional status and serum bilirubin

Answer

Nutritional status and serum creatinine

Answer

Serum bilirubin and acid phosphatase

Question 4

A 50-year-old man presents with a one-week history of fever and abdominal pain. An abdominal ultrasound revealed a hypoechoic liver lesion, and a CECT was performed for characterization. Which of the following statements regarding the lesion is false?

Accepted Answer

Hematogenous spread is the most common source of infection.

Answer

It is most commonly caused by E. coli bacterial infection.

Answer

The right lobe of the liver is the most common site.

Answer

All of the above statements are true.

Question 5

Okuda staging for HCC includes all except?

Accepted Answer

Prothrombin time

Answer

Ascites

Answer

Albumin

Answer

Tumor size

Question 6

Which of the following is a criterion for assessing the prognosis of a portosystemic shunt?

Accepted Answer

Type of shunt

Answer

Serum albumin

Answer

Resistant ascites

Answer

Serum bilirubin

Question 7

What is the ideal treatment for stenosis of the sphincter of Oddi?

Accepted Answer

Endoscopic sphincterotomy

Answer

Transduodenal sphincteroplasty

Answer

Choledochojejunostomy

Answer

Choledochoduodenostomy

Question 8

All of the following modalities can be used for in situ ablation of liver secondaries, except?

Accepted Answer

Ultrasonic waves

Answer

Alcohol

Answer

Radiofrequency ablation

Answer

Cryotherapy

Question 9

What is the most common cause of isolated gastric varices?

Accepted Answer

Splenic vein thrombosis

Answer

Profuse bleeding

Answer

Endoscopic ultrasound (EUS) is better than endoscopy

Answer

A single treatment can lead to eradication

Question 10

Which of the following statements is not true regarding Milan's criteria?

Accepted Answer

Fewer than 5 nodules

Answer

Single tumor <5 cm in size

Answer

Up to 3 nodules, each <3 cm in size

Answer

No extrahepatic spread

Hepatobiliary Surgery — MCQs

Hepatobiliary Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?